title: Initiating or blocking locomotion in spinal cats by applying noradrenergic drugs to restricted lumbar spinal segments.
abstract: After an acute low thoracic spinal transection (T13), cats can be made to walk with the hindlimbs on a treadmill with clonidine, an alpha2-noradrenergic agonist. Because previous studies of neonatal rat spinal cord in vitro suggest that the most important lumbar segments for rhythmogenesis are L1-L2, we investigated the role of various lumbar segments in the initiation of walking movements on a treadmill of adult cats spinalized (T13), 5-6 d earlier. The locomotor activities were evaluated from electromyographic and video recordings. The results show that: (1) localized topical application of clonidine in restricted baths over either the L3-L4 or the L5-L7 segments was sufficient to induce walking movements. Yohimbine, an alpha2-noradrenergic antagonist, could block this locomotion when applied over L3-L4 or L5-L7; (2) microinjections of clonidine in one or two lumbar segments from L3 to L5 could also induce locomotion; (3) after an intravenous injection of clonidine, locomotion was blocked by microinjections of yohimbine in segments L3, L4, or L5 but not if the injection was in L6; (4) locomotion was also blocked in all cases by additional spinal transections at L3 or L4. These results show that it is possible to initiate walking in the adult spinal cat with a pharmacological stimulation of a restricted number of lumbar segments and also that the integrity of the L3-L4 segments is necessary to sustain the locomotor activity.
authors.affiliation: Centre de Recherche en Sciences Neurologiques, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada H3T 1J4.
authors.forename: J
authors.initials: J
authors.lastname: Marcoux
authors.forename: S
authors.initials: S
authors.lastname: Rossignol
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000818:Animals; D002415:Cats; D003000:Clonidine / Q000008:administration & dosage*; D003655:Decerebrate State; D004558:Electric Stimulation; D004576:Electromyography; D005260:Female; D006614:Hindlimb / Q000294:innervation / Q000502:physiology; D007275:Injections, Intravenous; D008124:Locomotion / Q000187:drug effects* / Q000502:physiology; D008161:Lumbosacral Region; D008297:Male; D008845:Microinjections; D013116:Spinal Cord / Q000187:drug effects* / Q000473:pathology / Q000601:surgery; D013119:Spinal Cord Injuries / Q000188:drug therapy*; D013268:Stimulation, Chemical; D015016:Yohimbine / Q000008:administration & dosage
chemical_list: D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D015016:Yohimbine; D003000:Clonidine